Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,241 | 39,482 | 30,173 | 19,844 | 7,663 |
| Depreciation Amortization | 34 | 192 | 159 | 128 | 97 |
| Income taxes - deferred | 1,901 | 9,316 | 6,571 | 4,270 | 1,550 |
| Accounts receivable | -3,933 | -632 | -638 | -305 | 386 |
| Accounts payable and accrued liabilities | 2,371 | -1,488 | -1,504 | -1,332 | -1,697 |
| Other Working Capital | -8,659 | 5,022 | -515 | -7,944 | -7,061 |
| Other Operating Activity | 3,523 | 8,480 | 6,950 | 4,828 | 2,876 |
| Operating Cash Flow | $8,478 | $60,372 | $41,196 | $19,489 | $3,814 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -10,000 | -10,000 | -10,000 | -6,000 |
| PPE Investments | N/A | -1,021 | -980 | -912 | -911 |
| Investing Cash Flow | $N/A | $-11,021 | $-10,980 | $-10,912 | $-6,911 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,000 | 4,099 | 3,414 | 459 | 188 |
| Common Stock Repurchased | -2,551 | -12,089 | -9,014 | -3,961 | N/A |
| Other Financing Activity | 0 | -153 | -17 | -17 | 0 |
| Financing Cash Flow | $-1,551 | $-8,143 | $-5,617 | $-3,519 | $188 |
| Beginning Cash Position | 171,445 | 130,237 | 130,237 | 130,237 | 130,237 |
| End Cash Position | 178,372 | 171,445 | 154,836 | 135,295 | 127,328 |
| Net Cash Flow | $6,927 | $41,208 | $24,599 | $5,058 | $-2,909 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,478 | 60,372 | 41,196 | 19,489 | 3,814 |
| Capital Expenditure | N/A | -1,021 | -980 | -912 | -911 |
| Free Cash Flow | 8,478 | 59,351 | 40,216 | 18,577 | 2,903 |